ResearchMoz

Contraceptives Market (Drugs, Devices, Pills, Hormonal & Copper IUDs, Vaginal Rings, Subdermal Implants, Topical Contraceptives, Injectables, Diaphragms, Sponges, Male & Female Condoms) - Global Industry Analysis, Size, Share, Growth And Forecast, 2012 - 2018

Transparency Market Research
Published Date » 2013-05-14
No. Of Pages » 93
 
 Contraceptive drugs and devices are temporary birth control methods and function majorly by altering the mechanism of ovulation and acting as physical barriers between the sperm and ovary. This report holds the market estimation of the global contraceptives market in terms of value (USD million) for the period 2012 – 2018, considering the base year 2011 as. In addition, current market trends and recent developments are taken into consideration while determining the growth rate of the global contraceptives market. 
   
 The overall contraceptives market is categorized on the basis of products into two major categories namely contraceptive drugs and contraceptive devices. The contraceptive drugs market is further sub-segmented into contraceptive pills, injectables and...
Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Market Dynamics
3.1.1 Market Drivers
3.1.1.1 Growing Prevalence of Unwanted Pregnancies and High Global Prevalence of Women with Unmet Contraceptive Needs
3.1.1.2 Government and NGO Initiatives to Promote Contraceptive Products
3.1.1.3 Implementation of the Patient Protection Act or the Affordable Care Act
3.1.1.4 Rising Global Prevalence of Sexually Transmitted Infections (STI)
3.1.2 Impact Analysis of Market Drivers for the Global Contraceptives Market
3.1.3 Market Restraints
3.1.3.1 Side Effects Associated with the use of Contraceptive Drugs and Devices
3.1.3.2 Rapidly Aging Population and Rising Prevalence of Infertility
3.1.4 Impact Analysis of Market Restraints for the Global Contraceptives Market
3.1.5 Market Opportunities
3.1.5.1 Presence of Strong Contraceptives Pipeline
3.1.5.1.1 Male Contraceptive Drugs
3.1.5.1.2 AG200-15 Topical Contraceptive Patch
3.1.5.1.3 FC Patch Low
3.1.5.1.4 Pill-Plus
3.1.5.1.5 Other Products in Pipeline
3.1.5.2 Presence of Large Unmet Contraceptive Needs in Emerging Asian and African Economies
3.2 Porter’s Five Forces Analysis: Global Contraceptives Market
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of New Entrants
3.2.4 Threat of Substitutes
3.2.5 Competitive Rivalry
3.3 Market Attractiveness Analysis: Global Contraceptives Market, by Geography
3.4 Global Contraceptives Market, 2010 – 2018 (USD Million)

Chapter 4 Global Contraceptives Market, by Products
4.1 Overview
4.2 Global Contraceptive Drugs Market
4.2.1 Global Contraceptive Drugs Market, 2010 – 2018 (USD Million)
4.2.2 Global Oral Contraceptive Pills Market
4.2.2.1 Competitive Landscape: Global Oral Contraceptives Market, 2011
4.2.2.2 Global Oral Contraceptive Pills Market, 2010 – 2018 (USD Million)
4.2.3 Global Contraceptive Injectables Market
4.2.3.1 Competitive Landscape: Global Contraceptive Injectables Market, 2011
4.2.3.2 Global Contraceptive Injectables Market, 2010 – 2018 (USD Million)
4.2.4 Global Topical Contraceptives Market
4.2.4.1 Competitive Landscape: Global Topical Contraceptives Market
4.2.4.2 Global Topical Contraceptives Market, 2010 – 2018 (USD Million)
4.3 Global Contraceptive Devices Market
4.3.1 Global Male Contraceptive Devices (Male Condoms) Market
4.3.1.1 Competitive Landscape: Global Male Contraceptive Devices (Male Condoms) Market
4.3.1.2 Global Male Contraceptive Devices (Male Condoms) Market, 2010 – 2018 (USD Million)
4.3.2 Global Female Contraceptive Devices Market
4.3.2.1 Global Female Condoms Market
4.3.2.1.1 Global Female Condoms Market, 2010 – 2018 (USD Million)
4.3.2.2 Global Contraceptive Diaphragms Market
4.3.2.2.1 Global Contraceptive Diaphragms Market, 2010 – 2018 (USD Million)
4.3.2.3 Global Contraceptive Sponges Market
4.3.2.3.1 Competitive Landscape: Global Contraceptive Sponges Market
4.3.2.3.2 Global Contraceptive Sponges Market, 2010 – 2018 (USD Million)
4.3.2.4 Global Contraceptive Vaginal Rings Market
4.3.2.4.1 Global Contraceptive Vaginal Rings Market, 2010 – 2018 (USD Million)
4.3.2.5 Global Intrauterine Devices (IUD) Market
4.3.2.5.1 Global Copper IUD Market, 2010 – 2018 (USD Million)
4.3.2.5.2 Global Hormonal IUD Market, 2010 – 2018 (USD Million)
4.3.2.5.3 Competitive Landscape: Global IUD Market, 2011
4.3.2.6 Global Sub-dermal Contraceptive Implants Market
4.3.2.6.1 Global Sub-dermal Contraceptive Implants Market, 2010 – 2018 (USD Million)
4.3.2.6.2 Competitive Landscape: Global Sub-dermal Contraceptive Implants Market

Chapter 5 Global Contraceptives Market, by Geography
5.1 Overview
5.2 North America Contraceptives Market
5.2.1 North America Contraceptives Market, 2010 – 2018 (USD Million)
5.2.2 North America Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)
5.3 Europe Contraceptives Market
5.3.1 Europe Contraceptives Market, 2010 – 2018 (USD Million)
5.3.2 Europe Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)
5.4 Asia-Pacific Contraceptives Market
5.4.1 Asia-Pacific Contraceptives Market, 2010 – 2018 (USD Million)
5.4.2 Asia-Pacific Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)
5.5 Rest of the World (RoW) Contraceptives Market
5.5.1 RoW Contraceptives Market, 2010 – 2018 (USD Million)
5.5.2 RoW Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)

Chapter 6 Recommendations
6.1 Investing in Emerging Economies such as India and China and Underdeveloped African Economies
6.2 Making Rigorous R&D Initiatives
6.3 Investing in Marketing Campaigns to Elevate Customer Awareness
6.4 Tracking patent expiration of Branded Products

Chapter 7 Company Profiles
7.1 Merck & Co.
7.1.1 Company Profile
7.1.2 Financial Overview
7.1.3 Product Portfolio
7.1.4 Business Strategy
7.1.5 Recent Developments
7.2 Bayer  HealthCare AG
7.2.1 Company Profile
7.2.2 Financial Overview
7.2.3 Product Portfolio
7.2.4 Business Strategy
7.2.5 Recent Developments
7.3 Church & Dwight, Co. Inc.
7.3.1 Company Profile
7.3.2 Financial Overview
7.3.3 Product Portfolio
7.3.4 Business Strategy
7.3.5 Recent Developments
7.4 Warner Chilcott Company, Inc.
7.4.1 Company Profile
7.4.2 Financial Overview
7.4.3 Product Portfolio
7.4.4 Business Strategy
7.4.5 Recent Developments
7.5 Pfizer, Inc.
7.5.1 Company Overview
7.5.2 Financial Overview
7.5.3 Product Portfolio
7.5.4 Business Strategy
7.5.5 Recent Developments
7.6 Agile Therapeutics Inc.
7.6.1 Company Overview
7.6.2 Business Strategy
7.6.3 Product Portfolio
7.6.4 Recent Developments
7.7 BioSante Pharmaceuticals Inc.
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Business Strategy
7.7.4 Product Portfolio
7.7.5 Recent Developments
7.8 Mayer Laboratories, Inc.
7.8.1 Company Overview
7.8.2 Business Strategy
7.8.3 Product Portfolio
7.8.4 Recent Developments
7.9 Pantarhei Bioscience B.V.
7.9.1 Company Overview
7.9.2 Business Strategy
7.9.3 Product Portfolio
7.9.4 Recent Developments
7.10 Teva Pharmaceutical Industries Ltd.
7.10.1 Company Overview
7.10.2 Financial Overview
7.10.3 Business Strategy
7.10.4 Product Portfolio
7.10.5 Recent Developments

List of Tables


TABLE 1 Market Snapshot: Global Contraceptives Market
TABLE 2 Impact Analysis of Market Drivers for the Global Contraceptives Market
TABLE 3 Side Effects Associated with the Use of Contraceptive Drugs and Devices
TABLE 4 Impact Analysis of Market Restraints for the Global Contraceptives Market
TABLE 5 Contraceptive Products in Pipeline, Product Status and Manufacturer Names
TABLE 6 Global Contraceptives Market, by Product Types, 2010 – 2018 (USD Million)
TABLE 7 Global Contraceptives Drugs Market, by Product Types, 2010 – 2018 (USD Million)
TABLE 8 List of Latest Oral Contraceptive Pill Approvals, 2010 – 2012
TABLE 9 Global Female Contraceptive Devices Market, by Product Types, 2010 – 2018 (USD Million)
TABLE 10 Global IUD Market, by Product Types, 2010 – 2018 (USD Million)
TABLE 11 Global Contraceptives Market, by Geography, 2010 – 2018 (USD Million)
TABLE 12 North America Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)
TABLE 13 Europe Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)
TABLE 14 Asia-Pacific Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)
TABLE 15 RoW Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)

List of Figures


FIG. 1 Market Segmentation: Global Contraceptives Market
FIG. 2 Global Contraceptives Market, by Product Types, 2011 (USD Million)
FIG. 3 Global Population, by Age-Group, 2000 & 2050 (%)
FIG. 4 Average percentage of women with unmet contraceptive needs in the Southeast Asian, South Central Asian and Sub-Saharan African countries, 2011 (%)
FIG. 5 Porter’s Five Forces Analysis: Global Contraceptives Market
FIG. 7 Market Attractiveness Analysis: Global Contraceptives Market, by Geography
FIG. 8 Global Contraceptives Market, 2010 – 2018 (USD Million)
FIG. 9 Comparative Analysis of the Global Contraceptives Market, by Products, 2011 & 2018 (%)
FIG. 10 Comparative Analysis of the Global Contraceptive Drugs Market, by Product Types, 2011 & 2018 (%)
FIG. 11 Global Contraceptive Drugs Market, 2010 – 2018 (USD Million)
FIG. 12 Competitive Landscape by Market Players: Global Oral Contraceptives Market, 2011 (%)
FIG. 13 Global Oral Contraceptive Pills Market, 2010 – 2018 (USD Million)
FIG. 14 Competitive Landscape, by Brands: Global Contraceptive Injectables Market, 2011
FIG. 15 Global Contraceptive Injectables Market, 2010 – 2018 (USD Million)
FIG. 16 Global Topical Contraceptives Market, 2010 – 2018 (USD Million)
FIG. 17 Comparative Analysis of the Global Contraceptive Devices Market, by Product Types, 2011 & 2018 (%)
FIG. 18 Global Male Contraceptive Devices (Male Condoms) Market, 2010 – 2018 (USD Million)
FIG. 19 Global Female Condoms Market, 2010 – 2018 (USD Million)
FIG. 20 Global Female Diaphragms Market, 2010 – 2018 (USD Million)
FIG. 21 Global Contraceptive Sponges Market, 2010 – 2018 (USD Million)
FIG. 22 Global Contraceptive Vaginal Rings Market, 2010 – 2018 (USD Million)
FIG. 23 Comparative Analysis of the Global IUD Market, by Product Types, 2011 & 2018 (%)
FIG. 24 Global Copper IUD Market, 2010 – 2018 (USD Million)
FIG. 25 Global Hormonal IUD Market, 2010 – 2018 (USD Million)
FIG. 26 Global Sub-dermal Contraceptive Implants Market, 2010 – 2018 (USD Million)
FIG. 27 Comparative Analysis of the Global Contraceptives Market by Geography, 2011 & 2018 (%)
FIG. 28 North America Contraceptives Market, 2010 – 2018 (USD Million)
FIG. 29 Europe Contraceptives Market, 2010 – 2018 (USD Million)
FIG. 30 Asia-Pacific Contraceptives Market, 2010 – 2018 (USD Million)
FIG. 31 RoW Contraceptives Market, 2010 – 2018 (USD Million)
FIG. 32 Annual Revenues: Merck & Co.,  2009 - 2011 (USD million)
FIG. 33 Annual Revenues: Bayer HealthCare AG., 2009 – 2011 (USD Million) (1 Euro = 1.30 USD)
FIG. 34 Annual revenues: Church & Dwight Co. Inc., 2009 – 2011 (USD Million)
FIG. 35 Annual Revenues: Warner Chilcott Co. Inc.,   2009 - 2011 (USD million)
FIG. 36 Annual revenues: Pfizer Inc., 2009 – 2011 (USD Million)
FIG. 37 Annual Revenues: BioSante Pharmaceuticals Inc., 2009 – 2011 (USD Thousands)
FIG. 38 Annual Revenues: Teva Pharmaceutical Industries Ltd., 2009 – 2011 (USD Million)

Upcoming Reports:

Bone and Joints Ingredients Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Bone and joints ingredients are those elements which are taken as supplement in order to maintain healthy bones and joints. These value added ingredients help in increasing the strength and flexibility of the bones and joints in the body. There are various bone and joint ingredients including calcium, soy isoflavone and collagen. For instance, calcium is the most popular bone ingredient. It is an established ingredient with a mature market. Soy isoflavone is another key bone health ingredient maintaining bone mineral density (BMD) and preventing bone loss. The most important...
Food Encapsulation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2013 - 2019
By - Transparency Market Research
Food encapsulation is a method of stabilizing food ingredients to allow flavor retention, and remove bad taste. Food encapsulation involves techniques to immobilize cells for use within fermentation in food products such as beer, dairy, wine and meat. Consumer’s preference for healthy, tasty and convenient food products and these demands can be met by food encapsulation. Another application includes confectionary items such as chewing gums and candies which need encapsulated sweeteners in order to maintain sweetness over long periods of time. Due to changing lifestyles...
Enterovirus Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Enteroviruses are small, contagious single-stranded ribonucleic acid (RNA) viruses associated with several human and mammalian diseases. The enterovirus genus comprise 12 species which includes four major serotypes including poliovirus, coxsackievirus, echovirus and enterovirus. The newly identified enteroviruses are named with a system of consecutive numbers as EV68, EV69, EV70, etc. Enteroviruses are among the most common human viruses, infecting approximately one billion people annually, majorly infants and children. Diseases such as polio, meningitis, pancreatitis, hepatitis,...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Private Schools Have Higher Male Teaching Staff Than State Schools: Report
Oct 22, 2014  
Private and state education has always been a matter of debate across the UK. A recent study has shown that when it comes to teaching employment options, the difference between state-run and private education in terms of gender balance is absolutely clear.  A report by the Independent Schools Council (ISC) shows that while women dominate both the education medium, the number of...
Abbots First Australian Renewable Energy Deal Rejected
Oct 22, 2014  
The Abbot government’s initial deal for a renewable energy plan has been immediately rejected by the clean energy industry and Labor. The negotiations are about a bipartisan agreement regarding the future of the Australian renewable energy target. The Labor party rejected the first plan as being a job-killer before it was even announced. The plan, they said, would protect solar...
Chemical Production in Europe Flatlines in First Seven Months of 2014
Oct 21, 2014  
The recently published report by European Chemical Industry Council (Cefic) shows overall chemical production in Europe has flatlined in first seven months of this year. Though the initial four months showed a positive trend, the production volumes dropped in July 2014 and in the following months as well. The contraction in output in the three consecutive months has nullified the upward trend...
Actavis to Compete for Omega Pharma
Oct 20, 2014  
Actavic Plc has declared that it will become one of the bidders for the Omega Pharma NV deal, as the United States based drug maker keeps searching for more takeovers. Actavis will be competing against Boehringer Ingelheim GmbH, Sanofi and Perrigi Co. for Omega Pharma. Actavis places themselves as a potential suitor along with quarry in a multitude of potential pharma combinations....
Sale of iPhone Fuels UKs s
Oct 20, 2014  
With the sale of Apple Inc.’s latest smartphone, consumer expenditure on electronics has registered a three-year high this September. The new iPhone 6 and iPhone 6 Plus were launched in the U.K. on September 19 and buyers from across the country raced to purchase the newest smartphone. Both these smartphones are so far the fastest selling Apple products with a sale of over 10 million...